Adrenal Collision Tumor Composed of Pheochromocytoma and Diffuse Large B-Cell Lymphoma: A Case Report
-
Atieh Khorsand
,
Fatemeh Khatami
,
Salma Sefidbakht
,
Hiva Saffar
,
Alireza Sadeghipour
,
Seyed Mohammad Tavangar
Abstract
Adrenal involvement in the course of malignant lymphoma occurs in about 4% of patients, but primary adrenal lymphoma (PAL) is extremely rare. To the best of our knowledge, only one case study reported the combination of PAL with pheochromocytoma. In the current study, we present the second case who was a 63-year-old man admitted to our hospital with hematuria and abdominal discomfort. Ultrasound imaging indicated the presence of a lesion, 5×4×3 cm in size, in the upper pole of his right kidney. Histopathologic study confirmed a collision tumor composed of pheochromocytoma and diffuse large B-cell lymphoma (DLBCL).
Hatjiharissi E, Diamantidis M, Papaioannou M, Dimou T, Chrisoulidou A, Patakiouta F, et al. Long-term outcome of primary endocrine non-Hodgkin lymphomas: does the site make the difference? QJM: An International Journal of Medicine. 2013;106(7):623-30.
Juarez D, Brown RW, Ostrowski M, Reardon MJ, Lechago J, Truong LD. Pheochromocytoma associated with neuroendocrine carcinoma: a new type of composite pheochromocytoma. Archives of pathology & laboratory medicine. 1999;123(12):1274-9.
Haghpanah V, Soliemanpour B, Heshmat R, Mosavi-Jarrahi A, Tavangar S, Malekzadeh R, et al. Endocrine cancer in Iran: based on cancer registry system. Indian journal of cancer. 2006;43(2):80.
SHIRZAD M, MOHAGHEGHI S, HAGHPANAH V, MOUSAVI JS, TAVANGAR S, VASSIGH A, et al. Epidemiologic feature of thyroid cancer based on cancer registry data system. 2005.
Babinska A, Peksa R, Sworczak K. Primary malignant lymphoma combined with clinically “silent” pheochromocytoma in the same adrenal gland. World journal of surgical oncology. 2015;13(1):289.
Brady S, Lechan RM, Schwaitzberg S, Dayal Y, Ziar J, Tischler AS. Composite pheochromocytoma/ganglioneuroma of the adrenal gland associated with multiple endocrine neoplasia 2A: case report with immunohistochemical analysis. The American journal of surgical pathology. 1997;21(1):102-8.
Tatekawa Y, Muraji T, Nishijima E, Yoshida M, Tsugawa C. Composite pheochromocytoma associated with adrenal neuroblastoma in an infant: a case report. Journal of pediatric surgery. 2006;41(2):443-5.
Ch'ng E, Hoshida Y, Iizuka N, Morii E, Ikeda JI, Yamamoto A, et al. Composite malignant pheochromocytoma with malignant peripheral nerve sheath tumour: a case with 28 years of tumour‐bearing history. Histopathology. 2007;51(3):420-2.
Khan A, Solomon S, Childress R. Composite pheochromocytoma-ganglioneuroma: a rare experiment of nature. Endocrine Practice. 2009;16(2):291-9.
Untch BR, Shia J, Downey RJ, Carrasquillo JA, Panicek DM, Strong VE. Imaging and management of a small cell lung cancer metastasis/adrenal adenoma collision tumor: a case report and review of the literature. World journal of surgical oncology. 2014;12(1):45.
Hagspiel KD. Manifestation of Hodgkin’s lymphoma in an adrenal myelolipoma. European radiology. 2005;15(8):1757-9.
YILDIRIM S. Primary adrenal non-Hodgkin’s lymphoma: report of two cases. Turk J Gastroenterol. 2011;22(6):643-7.
Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. British journal of haematology. 2010;148(5):739-53.
Heavner MG, Krane LS, Winters SM, Mirzazadeh M. Pheochromocytoma diagnosed pathologically with previous negative serum markers. Journal of surgical oncology. 2015;112(5):492-5.
Sołtysiak M, Gołofit P, Łokaj M, Głowala J, Widecka K. Biochemically silent pheochromocytoma—rare, but not uncommon. Case study. Arterial Hypertension. 2015;19(4):200-2.
Wu D, Tischler AS, Lloyd RV, DeLellis RA, De Krijger R, Van Nederveen F, et al. Observer variation in the application of the Pheochromocytoma of the Adrenal Gland Scaled Score. The American journal of surgical pathology. 2009;33(4):599-608.
Sarmadi S, Izadi-Mood N, Sotoudeh K, Tavangar SM. Altered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometrium. Diagnostic pathology. 2009;4(1):41.
Kajbafzadeh A-M, Payabvash S, Salmasi AH, Monajemzadeh M, Tavangar SM. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction. The Journal of urology. 2006;176(2):718-23.
Tavangar SM, Shojaee A, Tabriz HM, Haghpanah V, Larijani B, Heshmat R, et al. Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma. Pathology-Research and Practice. 2010;206(5):305-9.
Haghpanah V, Shooshtarizadeh P, Heshmat R, Larijani B, Tavangar SM. Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma. Applied Immunohistochemistry & Molecular Morphology. 2006;14(4):422-5.
Mohammadi-asl J, Larijani B, Khorgami Z, Tavangar SM, Haghpanah V, Kheirollahi M, et al. Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinoma. Medical oncology. 2011;28(4):1123-8.
Sabetkish S, Kajbafzadeh AM, Sabetkish N, Khorramirouz R, Akbarzadeh A, Seyedian SL, et al. Whole‐organ tissue engineering: Decellularization and recellularization of three‐dimensional matrix liver scaffolds. Journal of biomedical materials research Part A. 2015;103(4):1498-508.
Omidfar K, Moinfar Z, Sohi AN, Tavangar SM, Haghpanah V, Heshmat R, et al. Expression of EGFRvIII in thyroid carcinoma: immunohistochemical study by camel antibodies. Immunological investigations. 2009;38(2):165-80.
Saffar H, Sanii S, Heshmat R, Haghpanah V, Larijani B, Rajabiani A, et al. Expression of galectin-3, nm-23, and cyclooxygenase-2 could potentially discriminate between benign and malignant pheochromocytoma. American journal of clinical pathology. 2011;135(3):454-60.
HAJI AMR, SABET KN, Heshmat R, Rajabiani A, Saffar H, Haghpanah V, et al. Expression of the pituitary tumor transforming gene (PTTG1) in pheochromocytoma as a potential marker for distinguishing benign versus malignant tumors. 2015.
| Files | ||
| Issue | Vol 12, No 4 (2018) | |
| Section | Case Report(s) | |
| DOI | https://doi.org/10.18502/ijhoscr.v12i4.101 | |
| Keywords | ||
| Collision tumor, Diffuse large B-cell lymphoma, Pheochromocytoma | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
